Drug intelligence / Profile preview

composite potassium hydrogen phosphate

Development stage
Unknown
Lead developer
Huaren Medical
Modality
Small Molecules
Administration
Intravenous
01

Overview

Composite potassium hydrogen phosphate injection is a sterile, non-pyrogenic solution containing potassium dihydrogen phosphate and dipotassium hydrogen phosphate. It is primarily used as a phosphorus supplement in total parenteral nutrition (TPN) therapy for patients who are unable to receive enteral nutrition, such as those undergoing major surgery or suffering from severe trauma requiring fasting for more than five days. It is also indicated for the correction of hypophosphatemia (low phosphorus levels) caused by various clinical conditions. The injection provides essential phosphate ions, which are crucial for intracellular energy metabolism, bone mineralization, and buffering systems, as well as potassium ions, which are vital for maintaining intracellular osmotic pressure and acid-base balance.

Brand names
AofantaiZeda奥凡泰泽达
Other names
composite potassium hydrogen phosphatecomposite potassium hydrogen phosphate injectioncompound potassium hydrogen phosphatecompound potassium hydrogen phosphate injection复方磷酸氢钾复方磷酸氢钾注射液复合磷酸氢钾复合磷酸氢钾注射液

Beyond the preview

Go deeper on composite potassium hydrogen phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on composite potassium hydrogen phosphate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call